patents.google.com

ATE393227T1 - Klonierung und charakterisierung von napsin, einer aspartat-protease - Google Patents

  • ️Thu May 15 2008

ATE393227T1 - Klonierung und charakterisierung von napsin, einer aspartat-protease - Google Patents

Klonierung und charakterisierung von napsin, einer aspartat-protease

Info

Publication number
ATE393227T1
ATE393227T1 AT97948546T AT97948546T ATE393227T1 AT E393227 T1 ATE393227 T1 AT E393227T1 AT 97948546 T AT97948546 T AT 97948546T AT 97948546 T AT97948546 T AT 97948546T AT E393227 T1 ATE393227 T1 AT E393227T1 Authority
AT
Austria
Prior art keywords
napsin
enzyme
protease
cloned
expressed
Prior art date
1996-11-20
Application number
AT97948546T
Other languages
English (en)
Inventor
Gerald Koelsch
Xinli Lin
Jordan Tang
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-11-20
Filing date
1997-11-20
Publication date
2008-05-15
1997-11-20 Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
2008-05-15 Application granted granted Critical
2008-05-15 Publication of ATE393227T1 publication Critical patent/ATE393227T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT97948546T 1996-11-20 1997-11-20 Klonierung und charakterisierung von napsin, einer aspartat-protease ATE393227T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3119696P 1996-11-20 1996-11-20
US4612697P 1997-05-09 1997-05-09

Publications (1)

Publication Number Publication Date
ATE393227T1 true ATE393227T1 (de) 2008-05-15

Family

ID=26706937

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948546T ATE393227T1 (de) 1996-11-20 1997-11-20 Klonierung und charakterisierung von napsin, einer aspartat-protease

Country Status (11)

Country Link
US (1) US6225103B1 (de)
EP (1) EP0948630B1 (de)
JP (2) JP2001503643A (de)
AT (1) ATE393227T1 (de)
AU (1) AU734220B2 (de)
CA (1) CA2271294A1 (de)
DE (1) DE69738653T2 (de)
DK (1) DK0948630T3 (de)
ES (1) ES2308791T3 (de)
PT (1) PT948630E (de)
WO (1) WO1998022597A2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897986A3 (de) * 1997-08-21 2000-07-05 Smithkline Beecham Corporation Aspartat proteinase 5 (ASP5)
US6432690B1 (en) 1998-01-16 2002-08-13 Incyte Genomics, Inc. Human aspartic proteases
US7045333B1 (en) * 1998-01-16 2006-05-16 Incyte Corporation Human protease molecules
US6203979B1 (en) 1998-01-16 2001-03-20 Incyte Pharmaceuticals, Inc. Human protease molecules
AU5213199A (en) * 1998-07-16 2000-02-07 Incyte Pharmaceuticals, Inc. Human aspartic proteases
EP1939297A1 (de) 1998-09-24 2008-07-02 Pharmacia & Upjohn Company LLC Alzheimerkrankheit-Sekretase
US7115410B1 (en) * 1999-02-10 2006-10-03 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
US7456007B1 (en) 1998-12-31 2008-11-25 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
CA2359785A1 (en) 1999-02-10 2000-08-17 John P. Anderson .beta.-secretase enzyme compositions and methods
US7514408B1 (en) 1999-12-02 2009-04-07 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
JP2001172200A (ja) * 1999-12-17 2001-06-26 Meneki Seibutsu Kenkyusho:Kk ヒトナプシンａに対する抗体およびこれを用いる医薬
WO2002000891A2 (en) * 2000-06-26 2002-01-03 Bayer Aktiengesellschaft Human napsin-like aspartyl protease
EP1666452A2 (de) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Verbindungen zur Behandlung der Alzheimerischen Krankheit
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
EP1500663A1 (de) * 2000-09-28 2005-01-26 Eli Lilly And Company Sekretierte proteine und ihre Verwendungen
US7806980B2 (en) * 2000-12-23 2010-10-05 Elan Pharmaceuticals, Inc. Method for crystallizing human beta secretase in complex with an inhibitor
US7601528B1 (en) 2000-12-23 2009-10-13 Elan Pharmaceuticals, Inc. Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
US7217556B1 (en) 2000-12-23 2007-05-15 Pfizer Inc Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease
US7524668B1 (en) 2001-05-10 2009-04-28 Elan Pharmaceuticals, Inc. Crystal of human beta secretase having monoclinic space group symmetry C2 and methods for crystallization thereof
US7384773B1 (en) * 2001-05-10 2008-06-10 Pfizer Inc Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof
WO2002098849A2 (en) 2001-06-01 2002-12-12 Elan Pharmaceuticals, Inc. Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
JP2004532894A (ja) 2001-06-13 2004-10-28 イーラン　ファーマスーティカルズ、インコーポレイテッド アルツハイマー病を治療するためのアミンジオール
US7067542B2 (en) 2001-07-10 2006-06-27 Pharmacia & Upjohn Company Diaminediols for the treatment of Alzheimer's disease
WO2003006453A1 (en) 2001-07-10 2003-01-23 Elan Pharmaceuticals, Inc. Aminediols for the treatment of alzheimer's disease
US7186539B1 (en) 2001-08-31 2007-03-06 Pharmacia & Upjohn Company Method for refolding enzymes
BR0213139A (pt) 2001-10-04 2004-08-10 Elan Pharm Inc Composto, método de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto e composição farmacêutica
NZ533107A (en) 2001-11-08 2007-04-27 Upjohn Co N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives
JP4272070B2 (ja) 2002-02-21 2009-06-03 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 修飾ｂａｃｅ
WO2004058686A1 (en) 2002-04-30 2004-07-15 Elan Pharmaceuticals, Inc. Hydroxypropyl amides for the treatment of alzheimer’s disease
US7442537B1 (en) 2002-05-10 2008-10-28 Elan Pharmaceuticals, Inc. Crystals of unliganded beta secretase and/or beta secretase-like proteins and the use thereof
WO2004009797A2 (en) * 2002-07-23 2004-01-29 Incyte Corporation Protein modification and maintenance molecules
US7351738B2 (en) 2002-11-27 2008-04-01 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
CL2004000849A1 (es) 2003-04-21 2005-01-28 Elan Pharmaceuticals Inc Pharm Compuestos derivados de benzamidas-2-hidroxi-3-diaminoalcanos, utiles para el tratamiento o la prevencion de alzheimer, sindrome de down, hemorragia cerebral hereditaria, demencias degenerativas y otras.
JP4739192B2 (ja) 2003-05-02 2011-08-03 イーラン ファーマスーティカルズ、インコーポレイテッド Ｂａｃｅのグリコシル化変異体
WO2005044977A2 (en) * 2003-06-25 2005-05-19 Diadexus, Inc. Compositions, splice variants and methods relating to lung specific genes and proteins
CA2558034A1 (en) 2004-03-09 2005-09-22 Elan Pharmaceuticals, Inc. Substituted hydroxyethylamine aspartyl protease inhibitors
US20070292346A1 (en) * 2004-03-25 2007-12-20 Rong Fan Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk
CA2573138A1 (en) 2004-07-09 2006-01-26 Elan Pharmaceuticals Inc. Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
WO2007047305A1 (en) 2005-10-12 2007-04-26 Elan Pharmaceuticals, Inc. Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
JP5450407B2 (ja) 2007-07-06 2014-03-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換アミノ−キナゾリノン、前記化合物を含む薬物、それらの使用及び製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107250A (en) * 1993-10-12 2001-08-08 Yeda Res & Dev Dna molecules involved in programmed cell death, proteins encoded thereby and methods and compositions using said dna molecules and proteins
GB9618966D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Novel compounds
US5776759A (en) * 1996-09-26 1998-07-07 Incyte Pharmaceuticals, Inc. Two novel human cathepsin proteins

Also Published As

Publication number Publication date
PT948630E (pt) 2008-06-11
EP0948630B1 (de) 2008-04-23
AU5459298A (en) 1998-06-10
CA2271294A1 (en) 1998-05-28
EP0948630A2 (de) 1999-10-13
AU734220B2 (en) 2001-06-07
WO1998022597A2 (en) 1998-05-28
DK0948630T3 (da) 2008-08-11
ES2308791T3 (es) 2008-12-01
DE69738653D1 (de) 2008-06-05
JP2001503643A (ja) 2001-03-21
DE69738653T2 (de) 2009-06-04
US6225103B1 (en) 2001-05-01
WO1998022597A3 (en) 1998-07-09
JP2008118996A (ja) 2008-05-29

Similar Documents

Publication Publication Date Title
DE69738653D1 (de) 2008-06-05 Klonierung und charakterisierung von napsin, einer aspartat-protease
Nishiura et al. 1978 The occurrence of an inhibitor of Ca2+-dependent neutral protease in rat liver
Collier et al. 1988 H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.
Mihara et al. 1991 A novel fibrinolytic enzyme extracted from the earthworm, Lumbricus rubellus
Fridman et al. 1992 Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions.
Shimamoto et al. 2001 Partial characterization of an enzyme fraction with protease activity which converts the spore peptidoglycan hydrolase (SleC) precursor to an active enzyme during germination of Clostridium perfringens S40 spores and analysis of a gene cluster involved in the activity
Cao et al. 2000 Identification of a myofibril-bound serine proteinase (MBSP) in the skeletal muscle of lizard fish Saurida wanieso which specifically cleaves the arginine site
Takada et al. 1985 Purification of human urinary prokallikrein. Identification of the site of activation by the metalloproteinase thermolysin
WO1998022597A9 (en) 1998-12-23 Cloning and characterization of napsin, an aspartic protease
Kohno et al. 1998 Two novel testicular serine proteases, TESP1 and TESP2, are present in the mouse sperm acrosome
Wei et al. 2001 Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta
Morita et al. 1981 [24] Prothrombin activator from Echis carinatus venom
Houen et al. 1996 The primary structure and enzymic properties of porcine prochymosin and chymosin
Nomura et al. 1997 Sea urchin hatching enzyme (envelysin): cDNA cloning and deprivation of protein substrate specificity by autolytic degradation
Yamauchi et al. 1994 Recombinant and native zymogen forms of human complement factor D.
AU739546B2 (en) 2001-10-18 Forms of prostate specific antigen and methods for their detection
Takahashi et al. 1981 Purification and characterization of porcine kidney cathepsin B
Hill et al. 1993 Human cathepsin E produced in E. coli
US4923818A (en) 1990-05-08 DNA clone of human type IV collagenase
Olalla et al. 1978 Purification and properties of three proteases from the larvae of the brine shrimp Artemia salina
GB2302874A (en) 1997-02-05 Human glandular kallikrein-1 proteases
Kurosaka et al. 1996 A 38 kDa precursor protein of aqualysin I (a thermophilic subtilisin‐type protease) with a C‐terminal extended sequence: its purification and in vitro processing
Mane et al. 2001 A study of extracellular alkaline protease from Bacillus subtilis NCIM 2713
CA1339874C (en) 1998-05-19 Dna clone of human type iv collagenase
Hitomi et al. 1998 Purification and characterization of the active-site-mutated recombinant human μ-calpain expressed in baculovirus-infected insect cells

Legal Events

Date Code Title Description
2008-11-15 UEP Publication of translation of european patent specification

Ref document number: 0948630

Country of ref document: EP